Literature DB >> 12469166

Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing.

Sonia Andersson1, Eva Rylander, Barbro Larson, Sunna Sigurdardottir, Ingrid Backlund, Jan Sällström, Erik Wilander.   

Abstract

In a collection of 173 cervical adenocarcinomas, the prevalence of HPV in relation to the age of women and the distribution of the various oncogenic types of HPV were evaluated. The tumour material was analysed by PCR of the HPV L1 gene followed by direct DNA sequencing and/or the polymerase chain reaction and single-strand conformation polymorphism (PCR-SSCP) technique for the identification and typing of HPV. In 68% (117/173) of the adenocarcinomas, HPV was present. A significant correlation was observed between the prevalence of HPV and age: in women younger than 40 years, HPV was present in 88%, whereas in women 60 years and older, it was found in only 39% (p<0.001). Among the HPV-positive tumours, type 18 predominated (52%) followed by type 16 (35%) and type 45 (7.7%) while other oncogenic types of HPV (31 and 59) were rarely found. HPV 16 was relatively more frequent in older women but this observation was not significant (p=0.06). HPV-typing by PCR and direct DNA sequence analysis is more specific than analysis by PCR-SSCP, especially among the less frequently occurring types of HPV. Our results further show that the prevalence of HPV in women with cervical adenocarcinomas is age-related and that the most frequently occurring types of HPV are 18, followed by 16 and 45. We have concluded that the oncogenic role of HPV in cervical squamous carcinomas and adenocarcinomas is, in some respects, discrepant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12469166

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  The carcinogenic role of oncogenic HPV and p53 gene mutation in cervical adenocarcinomas.

Authors:  S Andersson; A-C Hellström; Zhi-Ping Ren; E Wilander
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients.

Authors:  Alice C-H Chen; Tim Waterboer; Annie Keleher; Beth Morrison; Shalini Jindal; Denise McMillan; David Nicol; Robert A Gardiner; Nigel A J McMillan; Annika Antonsson
Journal:  Pathol Oncol Res       Date:  2011-01-16       Impact factor: 3.201

3.  p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.

Authors:  M Meftah El khair; M M Ennaji; R El kebbaj; R Ait Mhand; M Attaleb; M El Mzibri
Journal:  Med Oncol       Date:  2009-09-23       Impact factor: 3.064

4.  Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology.

Authors:  Joo-Young Kim; Byung Ho Nam; Jin-Ah Lee
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

5.  Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinoma.

Authors:  Li-Di Xu; Susanne Muller; Srinivasan R Thoppe; Fredrik Hellborg; Lena Kanter; Mikael Lerner; Biying Zheng; Svetlana Bajalica Lagercrantz; Dan Grandér; Keng Ling Wallin; Klas G Wiman; Catharina Larsson; Sonia Andersson
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

6.  Human papillomavirus genotypes distribution in cervical cancer cases in Gabon.

Authors:  Samira Zoa-Assoumou; Angelique Ndjoyi-Mbiguino; Barthelemy Mabika Mabika; Ernest Belembaogo; Abdelkim Khattabi; My Mustapha Ennaji
Journal:  Infect Agent Cancer       Date:  2016-08-16       Impact factor: 2.965

7.  The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma.

Authors:  Feng Zhou; Hao Chen; Meiping Li; Amanda L Strickland; Wenxin Zheng; Xiaofei Zhang
Journal:  Am J Surg Pathol       Date:  2022-03-01       Impact factor: 6.394

8.  Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix.

Authors:  F Erlandsson; H-S Martinsson-Ahlzén; K-L Wallin; A-C Hellström; S Andersson; A Zetterberg
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

9.  Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

Authors:  S Andersson; K-L Wallin; A-C Hellström; L E Morrison; A Hjerpe; G Auer; T Ried; C Larsson; K Heselmeyer-Haddad
Journal:  Br J Cancer       Date:  2006-07-18       Impact factor: 7.640

10.  Uterine cervix cancer treatment at Radiumhemmet: 90 years' experience. Time trends of age, stage, and histopathology distribution.

Authors:  Kristina Hellman; Ann-Cathrin Hellström; B Folke Pettersson
Journal:  Cancer Med       Date:  2014-01-14       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.